Breaking the chains: Advancements in antiviral strategies to combat Nipah virus infections
-
Published:2023-10
Issue:
Volume:
Page:122-133
-
ISSN:2455-8931
-
Container-title:International Journal of One Health
-
language:en
-
Short-container-title:Int J One Health
Author:
Orosco Fredmoore L.1ORCID
Affiliation:
1. Virology and Vaccine Institute of the Philippines Program, Industrial Technology Development Institute, Department of Science and Technology, Bicutan, Taguig City, 1634, Philippines; S & T Fellows Program, Department of Science and Technology, Bicutan, Taguig City, 1634, Philippines
Abstract
Nipah virus (NiV) is a highly pathogenic zoonotic virus that has caused several outbreaks with high fatality rates in humans and animals, thus, requiring a “One Health” approach. No specific treatment or vaccine is available for NiV infection, making the development of effective antiviral agents against this virus a critical research priority. In recent years, significant efforts have been made to identify and develop antiviral agents targeting the various stages of NiV pathogenesis. This review comprehensively discusses current research on antiviral agents against NiV. The promising results obtained with several compounds, including repurposed drugs, nucleoside analogs, phytochemicals, and multi-target inhibitors, are also highlighted. Developing effective antiviral agents against NiV remains a major challenge; however, recent advances in understanding the mechanisms of NiV pathogenesis and identifying potential targets for antiviral agents have provided hope for the future. Further research is required to identify and optimize antiviral agents with broad-spectrum activity against NiV and other related viruses.
Funder
Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development
Publisher
Veterinary World
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Health Policy,General Veterinary
Reference120 articles.
1. Thakur, N. and Bailey, D. (2019) Advances in diagnostics, vaccines and therapeutics for Nipah virus. Microbes Infect., 21(7): 278–286. 2. Paton, N.I., Leo, Y.S., Zaki, S.R., Auchus, A.P., Lee, K.E., Ling, A.E., Chew, S.K., Ang, B., Rollin, P.E., Umapathi, T., Sng, I., Lee, C.C., Lim, E. and Ksiazek, T.G. (1999) Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet, 354(9186): 1253–1256. 3. Johnson, K., Vu, M. and Freiberg, A.N. (2021) Recent advances in combating Nipah virus. Fac. Rev., 10: 74. 4. Ang, B.S.P., Lim, T.C.C. and Wang, L. (2018) Nipah virus infection. J. Clin. Microbiol., 56(6): e01875–17 . 5. Marsh, G.A., Jong, C., Barr, J.A., Tachedjian, M., Smith, C., Middleton, D., Yu, M., Todd, S., Foord, A.J., Haring, V., Payne, J., Robinson, R., Broz, I., Crameri, G., Field, H.E. and Wang, L.F. (2012) Cedar virus: A novel henipavirus isolated from Australian bats. PLOS Pathog., 8(8): e1002836.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|